Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 4
1982 3
1983 3
1984 3
1985 11
1986 8
1987 6
1988 7
1989 14
1990 10
1991 7
1992 18
1993 22
1994 21
1995 21
1996 19
1997 48
1998 55
1999 70
2000 78
2001 57
2002 66
2003 103
2004 130
2005 173
2006 195
2007 227
2008 252
2009 273
2010 346
2011 394
2012 500
2013 612
2014 651
2015 814
2016 898
2017 961
2018 1132
2019 1324
2020 1618
2021 1830
2022 2136
2023 2222
2024 1178
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

16,551 results

Results by year

Filters applied: . Clear all
Page 1
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: he z. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization.
Wang W, Li T, Cheng Y, Li F, Qi S, Mao M, Wu J, Liu Q, Zhang X, Li X, Zhang L, Qi H, Yang L, Yang K, He Z, Ding S, Qin Z, Yang Y, Yang X, Luo C, Guo Y, Wang C, Liu X, Zhou L, Liu Y, Kong W, Miao J, Ye S, Luo M, An L, Wang L, Che L, Niu Q, Ma Q, Zhang X, Zhang Z, Hu R, Feng H, Ping YF, Bian XW, Shi Y. Wang W, et al. Among authors: he z. Cancer Cell. 2024 May 13;42(5):815-832.e12. doi: 10.1016/j.ccell.2024.03.013. Epub 2024 Apr 18. Cancer Cell. 2024. PMID: 38640932 Free article.
Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration.
Liu X, Xin DE, Zhong X, Zhao C, Li Z, Zhang L, Dourson AJ, Lee L, Mishra S, Bayat AE, Nicholson E, Seibel WL, Yan B, Mason J, Turner BJ, Gonsalvez DG, Ong W, Chew SY, Ghosh B, Yoon SO, Xin M, He Z, Tchieu J, Wegner M, Nave KA, Franklin RJM, Dutta R, Trapp BD, Hu M, Smith MA, Jankowski MP, Barton SK, He X, Lu QR. Liu X, et al. Among authors: he z. Cell. 2024 May 9;187(10):2465-2484.e22. doi: 10.1016/j.cell.2024.04.005. Epub 2024 May 2. Cell. 2024. PMID: 38701782
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, Sun Y, Du X, Chi P, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Z, Zheng M, Xiao Y; RELARC Study Group. Xu L, et al. Among authors: he z. Lancet Oncol. 2021 Mar;22(3):391-401. doi: 10.1016/S1470-2045(20)30685-9. Epub 2021 Feb 12. Lancet Oncol. 2021. PMID: 33587893 Clinical Trial.
Micropeptides: potential treatment strategies for cancer.
Zhou H, Wu Y, Cai J, Zhang D, Lan D, Dai X, Liu S, Song T, Wang X, Kong Q, He Z, Tan J, Zhang J. Zhou H, et al. Among authors: he z. Cancer Cell Int. 2024 Apr 15;24(1):134. doi: 10.1186/s12935-024-03281-w. Cancer Cell Int. 2024. PMID: 38622617 Free PMC article. Review.
Emerging Chemodynamic Nanotherapeutics for Cancer Treatment.
Sun D, Sun X, Zhang X, Wu J, Shi X, Sun J, Luo C, He Z, Zhang S. Sun D, et al. Among authors: he z. Adv Healthc Mater. 2024 May 16:e2400809. doi: 10.1002/adhm.202400809. Online ahead of print. Adv Healthc Mater. 2024. PMID: 38752756 Review.
Bacteroides and NAFLD: pathophysiology and therapy.
Zhang J, Zhou J, He Z, Li H. Zhang J, et al. Among authors: he z. Front Microbiol. 2024 Mar 20;15:1288856. doi: 10.3389/fmicb.2024.1288856. eCollection 2024. Front Microbiol. 2024. PMID: 38572244 Free PMC article. Review.
Reflections on COPD comorbidities.
He Z, Wang Y, Shan L, Mou Y, Liu Y, Ma G, Wu Y, Zhu H, Curtis JL, Cui S, Ge H. He Z, et al. Chin Med J (Engl). 2024 May 16. doi: 10.1097/CM9.0000000000003131. Online ahead of print. Chin Med J (Engl). 2024. PMID: 38750633 No abstract available.
Advances in the study of S100A9 in cardiovascular diseases.
Chen F, He Z, Wang C, Si J, Chen Z, Guo Y. Chen F, et al. Among authors: he z. Cell Prolif. 2024 Mar 19:e13636. doi: 10.1111/cpr.13636. Online ahead of print. Cell Prolif. 2024. PMID: 38504474 Review.
16,551 results
You have reached the last available page of results. Please see the User Guide for more information.